This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
An intro to the components behind the S&P 500 index value, including inputs and how they combine to form the level.
27,867 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
A large stake exit sent shockwaves through a payments stock, pulling it down by about half from its highs. This artic...
Bloom Energy has sprinted higher this year on an AI-powered energy story. As a late entrant, you’ll want a clear view...
Spotting a strong real estate market isn’t guesswork. By watching a few proven metrics that matter: spot—rent growth,...
When TOI releases earnings, investors watch more than headline numbers. This guide breaks down TOI earnings, what dri...
Thomas Siebel’s return as C3.AI CEO could reshape sales strategy and investor sentiment. This article breaks down wha...
Could a Palantir competitor deliver the kind of upside that fans of AI software chase? This article breaks down the c...
Investing in builders requires more than chasing growth. This deep dive unpacks why dream finders homes: promising st...
AI is nearing a dramatic turning point. Wedbush predicts a 2026 inflection, and this article explains what that means...
Meta Platforms is navigating a bold AI infrastructure push that could redefine profits. This guide breaks down the ri...
Discover how general mills (gis) 2026 could unfold, with a focus on brand strength, cost discipline, and capital allo...
Explore how Uri Levine’s problem-first approach fuels startup success, from Waze’s ascent to the future of autonomous...